EDGAR Filing Documents for 0001193125-05-056792

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-05-056792

Filing Date

2005-03-21

Accepted

2005-03-21 17:23:32

Documents

Period of Report

2004-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d10k.htm	10-K	1099248
2	FORM OF NOTICE OF GRANT OF STOCK OPTIONS	dex1088.htm	EX-10.88	7377
3	STOCK OWNERSHIP POLICY	dex1089.htm	EX-10.89	7464
4	SUBSIDIARIES OF REGISTRANT	dex21.htm	EX-21	1286
5	CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	dex231.htm	EX-23.1	2033
6	CONSENT OF HASKELL WHITE LLP, INDEPENDENT REGISTERED PUBLIC ACCOUTING FIRM	dex232.htm	EX-23.2	2052
7	CERTIFICATION OF CHIEF EXECUTIVE OFFICER - SECTION 302	dex311.htm	EX-31.1	9142
8	CERTIFICATION OF CHIEF FINANCIAL OFFICER - SECTION 302	dex312.htm	EX-31.2	9162
9	CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - SECTION 906	dex32.htm	EX-32	5303
	Complete submission text file	0001193125-05-056792.txt		1145756

Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718

Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157

CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)